Share This Page
Drug Price Trends for PIPERACIL-TAZOBACT
✉ Email this page to a colleague
Average Pharmacy Cost for PIPERACIL-TAZOBACT
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| PIPERACIL-TAZOBACT 3.375 GM VL | 25021-0165-30 | 3.06584 | EACH | 2025-03-19 |
| PIPERACIL-TAZOBACT 3.375 GM VL | 00781-9213-95 | 3.06584 | EACH | 2025-03-19 |
| PIPERACIL-TAZOBACT 3.375 GM VL | 81284-0152-10 | 3.06584 | EACH | 2025-03-19 |
| PIPERACIL-TAZOBACT 3.375 GM VL | 00409-3385-13 | 3.06584 | EACH | 2025-03-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Piperacillin and Tazobactam
Introduction
Piperacillin and Tazobactam, a combination of a penicillin antibiotic and a beta-lactamase inhibitor, is widely used to treat various bacterial infections. This market analysis will delve into the current market size, growth projections, key players, and price trends for this crucial antibiotic combination.
Market Size and Growth Projections
The global market for Piperacillin and Tazobactam is expected to exhibit steady growth over the forecast period.
- API Market: The global Piperacillin and Tazobactam API market was valued at US$ 217 million in 2023 and is forecasted to reach US$ 247.7 million by 2030, growing at a CAGR of 1.0% during the period 2024-2030[1].
- Injection Market: The Piperacillin and Tazobactam for Injection market is more expansive, valued at USD 53.07 billion in 2023 and projected to reach USD 68.08 billion by 2030, with a CAGR of 4.3% during the forecast period[3].
Key Players
The market is dominated by several major pharmaceutical companies, including:
- Pfizer Healthcare
- Fresenius Kabi
- Qilu Pharmaceutical
- Aurobindo Pharma
- Sandoz
- NCPC
- REYOUNG
- Yuhan Corporation
- LKPC
- Nectar Lifesciences
- Sterile India
- Suanfarma
- Rajasthan Antibiotics[1][3][4].
Market Segmentation
The market is segmented based on type, application, and geography.
By Type
- Piperacillin
- Tazobactam
- Piperacillin and Tazobactam Combination[1][4].
By Application
- Injection
- Used in hospitals and clinics for treating various bacterial infections.
- Compound Injection
- Often used in combination with other antibiotics or drugs to enhance efficacy[1][4].
By Geography
The market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Each region has its own set of key players and market dynamics[3][4].
Price Trends
The prices of Piperacillin and Tazobactam vary based on the dosage and form of the drug.
- Intravenous Powder for Injection:
- For a 4 g-0.5 g dose, the price ranges from $66.72 to $168.62 for a supply of 10 powder for injection[5].
- Other dosages like 2 g-0.25 g and 3 g-0.375 g also have varying price ranges, generally between $40 to $133 per 10 powder for injection[5].
Market Drivers and Challenges
Drivers
- Increasing Demand: The growing incidence of bacterial infections and the need for effective antibiotics drive the demand for Piperacillin and Tazobactam[3].
- Hospital and Clinic Usage: The widespread use in healthcare settings, particularly in hospitals and clinics, contributes significantly to market growth[3].
Challenges
- Antibiotic Resistance: The rising issue of antibiotic resistance poses a significant challenge to the market, as it may reduce the efficacy of Piperacillin and Tazobactam over time[4].
- Regulatory Frameworks: Strict regulatory requirements and the need for continuous clinical trials can be challenging for manufacturers[4].
Competitive Landscape
The competitive landscape is highly fragmented with multiple players competing based on product offerings, pricing, and geographical presence.
"The market report lists the major players involved in the Piperacillin and Tazobactam for Injection Market under the competitive landscape and company profile chapters. The major players in the market are evaluated based on their product and/or service offerings, financial statements, key developments, strategic approach to the market, position in the market, geographical penetration, and other key features."[3]
Regional Analysis
The market is geographically segmented into North America, Europe, Asia Pacific, and the Rest of the World. Each region has its unique market dynamics and growth prospects.
- Asia Pacific: This region is expected to show significant growth due to the large population and increasing healthcare expenditure[3].
- North America and Europe: These regions are mature markets with a high demand for advanced healthcare solutions, including Piperacillin and Tazobactam[3].
Forecast and Projections
API Market
- The API market is expected to grow at a CAGR of 1.0% from 2024 to 2030, reaching a market size of US$ 247.7 million by 2030[1].
Injection Market
- The injection market is projected to grow at a CAGR of 4.3% from 2023 to 2030, reaching a market size of USD 68.08 billion by 2030[3].
Key Takeaways
- The global Piperacillin and Tazobactam market is driven by increasing demand and widespread use in healthcare settings.
- The market is segmented by type, application, and geography, with key players competing based on product offerings and pricing.
- The API market and injection market have different growth projections, with the injection market showing more robust growth.
- Challenges such as antibiotic resistance and regulatory frameworks need to be addressed by manufacturers.
Frequently Asked Questions (FAQs)
1. What is the forecasted market size for Piperacillin and Tazobactam API by 2030? The Piperacillin and Tazobactam API market is forecasted to reach US$ 247.7 million by 2030[1].
2. Which companies are the major players in the Piperacillin and Tazobactam market? Major players include Pfizer Healthcare, Fresenius Kabi, Qilu Pharmaceutical, Aurobindo Pharma, Sandoz, and others[1][3][4].
3. What are the primary applications of Piperacillin and Tazobactam? The primary applications are injection and compound injection, used in hospitals and clinics to treat bacterial infections[1][4].
4. What is the CAGR for the Piperacillin and Tazobactam injection market from 2023 to 2030? The CAGR for the injection market is 4.3% from 2023 to 2030[3].
5. How do prices vary for different dosages of Piperacillin and Tazobactam? Prices vary significantly based on dosage, with a 4 g-0.5 g dose ranging from $66.72 to $168.62 for a supply of 10 powder for injection[5].
Sources:
- Valuates Reports: Piperacillin and Tazobactam API - Market Size.
- QYResearch: Global Piperacillin and tazobactam Injection Market Insights, Forecast to 2030.
- Verified Market Reports: Piperacillin and Tazobactam for Injection Market Growth.
- ResearchAndMarkets: Global Piperacillin Sodium (CAS 59703 84 3) Market Report 2022.
- Drugs.com: Piperacillin/tazobactam Prices, Coupons, Copay Cards & Patient Assistance.
More… ↓
